Lawrence Blonde, MD, FACP, FACE


Achieving Antihyperglycemic Treatment Goals With Incretin-Related Therapies

November 30, 2012

The management of type 2 diabetes mellitus (T2DM) remains challenging. Limitations associated with many current therapies include hypoglycemia and weight gain. An increased understanding of the pathophysiology of T2DM has led to the development of incretin-related antihyperglycemic therapies.